Free Trial
LON:MTFB

Motif Bio (MTFB) Share Price, News & Analysis

Motif Bio logo

About Motif Bio Stock (LON:MTFB)

Key Stats

Today's Range
N/A
50-Day Range
0.50
0.50
52-Week Range
N/A
Volume
N/A
Average Volume
33.38 million shs
Market Capitalization
£3.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Motif Bio plc does not have any significant operations. It intends to identify a reverse takeover or other strategic transaction. Previously, the company was engaged in developing and commercializing pharmaceutical formulations. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Receive MTFB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motif Bio and its competitors with MarketBeat's FREE daily newsletter.

MTFB Stock News Headlines

MTFB.L Share Chat
MTFB.L Regulatory News
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
The Christian history of the Green Man motif
Ochre Bio Announces Participation in Upcoming Conferences
MTFB_old Historical Data
Motif Bio plc ADRs(MTFB)
See More Headlines

MTFB Stock Analysis - Frequently Asked Questions

Shares of MTFB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Motif Bio investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Sirius Minerals (SXX), Egdon Resources (EDR), BlackRock (BLK), Endologix (ELGX) and Global Blood Therapeutics (GBT).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
GBX 15.50 per share

Miscellaneous

Free Float
N/A
Market Cap
£3.28 million
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (LON:MTFB) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners